|
[1] GINES A,ESCORSELL A,GINES P,et al. Incidence,predictive factors,and prognosis of the hepatorenal syndrome in cirrhosis with ascites[J]. Gastroenterology,1993,105(1):229-236.
|
|
[2] OLIVERA-MARTINEZ M,SAYLES H,VIVEKANANDAN R,et al. Hepatorenal syndrome:Are we missing some prognostic factors?[J]. Dig Dis Sci,2012,57(1):210-214.
|
|
[3] AMIN AA,ALABSAWY EI,JALAN R,et al. Epidemiology,pathophysiology,and management of hepatorenal syndrome[J]. Semin Nephrol,2019,39(1):17-30.
|
|
[4] RIVOLTA R,MAGGI A,CAZZANIGA M,et al. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites[J]. Hepatology,1998,28(5):1235-1240.
|
|
[5] MINDIKOGLU AL,DOWLING TC,WONG-YOU-CHEONG JJ,et al. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate,renal plasma flow,renal resistive indices and biomarkers measurements[J]. Am J Nephrol,2014,39(6):543-552.
|
|
[6] MINDIKOGLU AL,PAPPAS SC. New developments in hepatorenal syndrome[J]. Clin Gastroenterol Hepatol,2018,16(2):162-177. e1.
|
|
[7] LLUCH P,MAURICIO MD,VILA JM,et al. Accumulation of symmetric dimethylarginine in hepatorenal syndrome[J]. Exp Biol Med(Maywood),2006,231(1):70-75.
|
|
[8] NIJVELDT RJ,TEERLINK T,SIROEN MP,et al. The liver is an important organ in the metabolism ofasymmetrical dimethylarginine(ADMA)[J]. Clin Nutr,2003,22(1):17-22.
|
|
[9] NIJVELDT RJ,TEERLINK T,van LEEUWEN PA. The asymmetrical dimethylarginine(ADMA)-multiple organ failure hypothesis[J]. Clin Nutr,2003,22(1):99-104.
|
|
[10] MARTIN PY,GINES P,SCHRIER RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis[J]. N Engl J Med,1998,339(8):533-541.
|
|
[11] NIJVELDT RJ,TEERLINK T,van der HOVEN B,et al. Asymmetrical dimethylarginine(ADMA)in critically ill patients:High plasma ADMA concentration is an independent risk factor of ICU mortality[J]. Clin Nutr,2003,22(1):23-30.
|
|
[12] VALLANCE P,LEONE A,CALVER A,et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure[J]. Lancet,1992,339(8793):572-575.
|
|
[13] MINDIKOGLU AL,DOWLING TC,MAGDER LS,et al. Estimation of glomerular filtration rate in patients with cirrhosis by using new and conventional filtration markers and dimethylarginines[J]. Clin Gastroenterol Hepatol,2016,14(4):624-632. e2.
|
|
[14] Chinese Society of Hepatology,Chinese Medical Association.Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol,2019,35(11):2408-2425.(in Chinese)中华医学会肝病学分会．肝硬化诊治指南[J]．临床肝胆病杂志，2019,35(11):2408-2425.
|
|
[15] NAZAR A,GUEVARA M,SITGES M,et al. LEFT ventricular function assessed by echocardiography in cirrhosis:Relationship to systemic hemodynamics and renal dysfunction[J]. J Hepatol,2013,58(1):51-57.
|
|
[16] KAZORY A,RONCO C. Hepatorenal syndrome or hepatocardiorenal syndrome:Revisiting basic concepts in view of emerging data[J]. Cardiorenal Med,2019,9(1):1-7.
|
|
[17] RUIZ-DEL-ARBOL L,MONESCILLO A,AROCENA C,et al. Circulatory function and hepatorenal syndrome in cirrhosis[J]. Hepatology,2005,42(2):439-447.
|
|
[18] NADIM MK,KELLUM JA,DAVENPORT A,et al. Hepatorenal syndrome:The 8th international consensus conference of the Acute Dialysis Quality Initiative(ADQI)group[J]. Crit Care,2012,16(1):r23.
|
|
[19] THABUT D,MASSARD J,GANGLOFF A,et al. Model for endstage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure[J]. Hepatology,2007,46(6):1872-1882.
|
|
[20] CLARIA J,STAUBER RE,COENRAAD MJ,et al. Systemic inflammationin decompensated cirrhosis:Characterization and role in acuteon-chronic liver failure[J]. Hepatology,2016,64:1249-1264.
|
|
[21] JO SK,CHA DR,CHO WY,et al. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells[J]. Nephron,2002,91(3):406-415.
|
|
[22] NAVASA M,FOLLO A,FILELLA X,et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis:Relationship with the development of renal impairment and mortality[J]. Hepatology,1998,27(5):1227-1232.
|
|
[23] SHAH N,MOHAMED FE,JOVER-COBOS M,et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis[J]. Liver Int,2013,33(3):398-409.
|
|
[24] SHAH N,DHAR D,EL ZAHRAA MOHAMMED F,et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression[J]. J Hepatol,2012,56(5):1047-1053.
|
|
[25] FERNANDEZ J,NAVASA M,PLANAS R,et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis[J]. Gastroenterology,2007,133(3):818-824.
|
|
[26] WONG F,PAPPAS SC,BOYER TD,et al. Terlipressin improves renal function and reverses hepatorenal syndrome in patients with systemic inflammatory response syndrome[J].Clin Gastroenterol Hepatol,2017,15(2):266-272. e1.
|
|
[27] ACEVEDO J,FERNANDEZ J,PRADO V,et al. Relative adrenal insufficiency in decompensated cirrhosis:Relationship to short-term risk of severe sepsis,hepatorenal syndrome,and death[J]. Hepatology,2013,58(5):1757-1765.
|
|
[28] THEOCHARIDOU E,KRAG A,BENDTSEN F,et al. Cardiac dysfunction in cirrhosis-does adrenal function play a role? A hypothesis[J]. Liver Int,2012,32(9):1327-1332.
|
|
[29] van SLAMBROUCK CM,SALEM F,MEEHAN SM,et al. Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction[J]. Kidney Int,2013,84(1):192-197.
|
|
[30] BARRETO R,FAGUNDES C,GUEVARA M,et al. Type-1 hepatorenal syndrome associated with infections in cirrhosis:Natural history,outcome of kidney function,and survival[J]. Hepatology,2014,59(4):1505-1513.
|
|
[31] TRAWALEJM,PARADIS V,RAUTOU PE,et al. The spectrum of renal lesions in patients with cirrhosis:A clinicopathological study[J]. Liver Int,2010,30(5):725-732.
|
|
[32] MEHTA G,MOOKERJEE RP,SHARMA V,et al. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure[J]. Liver Int,2015,35(3):724-734.
|
|
[33] DAVENPORT A,SHEIKH MF,LAMB E,et al. Acute kidney injury in acute-on-chronic liver failure:Where does hepatorenal syndrome fit?[J]. Kidney Int,2017,92(5):1058-1070.
|
|
[34] ANGELI P,GARCIA-TSAO G,NADIM MK,et al. News in pathophysiology,definition and classification of hepatorenal syndrome:A step beyond the International Club of Ascites(ICA)consensus document[J]. J Hepatol,2019,71(4):811-822.
|
DownLoad: